Dalian BIO-CHEM Company Limited

603360.SS · SHH
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
RevenueCN¥1,312CN¥1,066CN¥1,257CN¥1,006
% Growth23.1%-15.2%24.9%
Cost of Goods SoldCN¥738CN¥521CN¥616CN¥557
Gross ProfitCN¥574CN¥545CN¥641CN¥450
% Margin43.8%51.1%51%44.7%
R&D ExpensesCN¥50CN¥39CN¥47CN¥40
G&A ExpensesCN¥93CN¥107CN¥121CN¥79
SG&A ExpensesCN¥111CN¥121CN¥132CN¥92
Sales & Mktg Exp.CN¥18CN¥14CN¥11CN¥12
Other Operating Expenses-CN¥1-CN¥1-CN¥0CN¥15
Operating ExpensesCN¥159CN¥159CN¥179CN¥147
Operating IncomeCN¥415CN¥386CN¥462CN¥303
% Margin31.6%36.2%36.7%30.1%
Other Income/Exp. Net-CN¥0-CN¥0-CN¥0-CN¥11
Pre-Tax IncomeCN¥414CN¥386CN¥461CN¥292
Tax ExpenseCN¥55CN¥57CN¥59CN¥42
Net IncomeCN¥345CN¥328CN¥403CN¥250
% Margin26.3%30.8%32%24.9%
EPS0.680.661.20.71
% Growth3%-45%69%
EPS Diluted0.680.931.20.71
Weighted Avg Shares Out508353335351
Weighted Avg Shares Out Dil508353335354
Supplemental Information
Interest IncomeCN¥17CN¥19CN¥4CN¥6
Interest ExpenseCN¥8CN¥5CN¥5CN¥13
Depreciation & AmortizationCN¥69CN¥64CN¥71CN¥48
EBITDACN¥464CN¥440CN¥517CN¥353
% Margin35.3%41.3%41.1%35.1%
Dalian BIO-CHEM Company Limited (603360.SS) Financial Statements & Key Stats | AlphaPilot